Analysis – Page 244 – Goldea Capital

Figure Technology Solutions to Participate in Upcoming Investor Conferences

Written by Customer Service on May 20, 2026. Posted in Public Companies.

NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) — Figure Technology Solutions (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale and trading of tokenized assets, today announced the company will be participating in the following upcoming investor conferences:Bernstein 42nd Annual Strategic Decisions Conference (New York, NY)Presentation on Wednesday, May 27th at 3:30 p.m. ETPiper Sandler Global Exchange & FinTech Conference (New York, NY)Presentation on Wednesday, June 3rd at 2:00 p.m. ETInterested parties may access a live audio webcast of the presentations by visiting https://investors.figure.com/. Following the presentation, a recording will be available for replay for at least 90 days at the same link. About Figure Technology Solutions, Inc Figure Technology Solutions,...

Victoria’s Secret & Co. Issues Investor Presentation Highlighting Significant Transformation, Operational Momentum and Shareholder Value Creation

Written by Customer Service on May 20, 2026. Posted in Public Companies.

VS&Co Board and Management are Delivering Significant Operational and TSR Outperformance Under New Leadership and “Path to Potential” Strategy BBRC’s Campaign Ignores Meaningful Progress and Seeks to Disrupt Path to Potential with Self-Interested Narratives and Misleading Claims VS&Co Urges Shareholders to Vote “FOR” All Highly Qualified Directors at the 2026 Annual Meeting of Shareholders REYNOLDSBURG, Ohio, May 20, 2026 (GLOBE NEWSWIRE) — Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) today announced that it has filed a detailed investor presentation titled “Vote for Victoria’s Secret’s Board and Our Continued Momentum.” The presentation highlights the Company’s strong operational and financial momentum under its Path to Potential strategy, as well as the decisive actions taken by the Board...

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Written by Customer Service on May 20, 2026. Posted in Public Companies.

WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to 17 newly hired employees. The awards were made as an inducement material to the newly hired employees’ acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement equity awards consisted of non-statutory stock options to purchase up to an aggregate of 296,500 shares of Dyne’s common stock at a per share exercise price equal to the closing price of Dyne’s common stock on The Nasdaq Global Select Market on May 20, 2026, and restricted stock units with respect to an aggregate of 94,100 shares of Dyne’s common...

Aperture AC Announces the Pricing of $90,000,000 Initial Public Offering

Written by Customer Service on May 20, 2026. Posted in Public Companies.

Los Angeles, CA, May 20, 2026 (GLOBE NEWSWIRE) — Aperture AC (the “Company”) announced today the pricing of its initial public offering of 9,000,000 units at a price of $10.00 per unit. The units are expected to be listed on the Nasdaq Capital Market (“Nasdaq”) and begin trading tomorrow, May 21, 2026, under the ticker symbol “APURU.” Each unit consists of one Class A ordinary share and one right (the “Share Right”) to receive one-fourth (1/4) of one Class A ordinary share upon the consummation of an initial business combination. Once the securities constituting the units begin separate trading, the Class A ordinary shares and Share Rights are expected to be listed on Nasdaq under the symbols “APUR” and “APURR,” respectively. The offering is expected to close on May 22, 2026, subject to customary closing conditions. The Company...

Enviri Announces Merger Consideration for Sale of Clean Earth and Update Regarding Spin-Off of New Enviri

Written by Customer Service on May 20, 2026. Posted in Public Companies.

Sale of Clean Earth and Spin-off of Harsco Environmental and Rail expected to be completed on June 1, 2026 Enviri stockholders to receive $15.00 per share at closing, after debt repayment, transaction costs and other financial considerations Effective date for distribution in Spin-off of Harsco Environmental and Rail is expected to be June 1, 2026 (the “Effective Date”) Enviri stockholders will receive one share of New Enviri common stock for every three shares of Enviri common stock on June 1, 2026 Enviri II Corporation (“New Enviri”) “When Issued” trading expected to begin on May 27, 2026 under symbol “NVRI WI” and “Regular Way” trading expected to begin on June 2, 2026 under the new name “Enviri Corporation” and symbol “NVRI”PHILADELPHIA, May 20, 2026 (GLOBE NEWSWIRE) — As previously announced, Enviri Corporation (NYSE: NVRI)...

Skyworks Commences Exchange Offers and Consent Solicitations for Qorvo’s Senior Notes due 2029 and 2031

Written by Customer Service on May 20, 2026. Posted in Mergers And Acquisitions.

IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) — Skyworks Solutions, Inc. (Nasdaq: SWKS) (“Skyworks”), a leading developer, manufacturer and provider of analog and mixed-signal semiconductors and solutions for numerous applications, today announced that, in connection with its anticipated acquisition of Qorvo, Inc. (“Qorvo”), Skyworks has commenced offers to holders of Qorvo Notes (as defined below) to exchange (the “Exchange Offers”) any and all outstanding 4.375% Senior Notes due 2029 (the “2029 Qorvo Notes”) and any and all outstanding 3.375% Senior Notes due 2031 issued by Qorvo (the “2031 Qorvo Notes” and, together with the 2029 Qorvo Notes, the “Qorvo Notes”), for, (1) with respect to the 2029 Qorvo Notes, up to $850,000,000 aggregate principal amount of new 4.375% Senior Notes due 2029 (the “New 2029 Skyworks Notes”) issued...

iPower Reports Fiscal Third Quarter 2026 Results Highlighted by Lower Operating Cost Structure, Narrowed Non-GAAP Loss and Advancing AI Infrastructure Strategy

Written by Customer Service on May 20, 2026. Posted in Earnings Releases And Operating Results.

Operating expenses declined 66% sequentially GAAP net loss primarily reflected non-cash goodwill impairment; non-GAAP net loss narrowed to $0.3 million Company strengthens platform through asset-light operations, contracted sublease income and recently launched AI infrastructure strategy RANCHO CUCAMONGA, Calif., May 20, 2026 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a technology- and data-driven company operating at the intersection of supply chain, infrastructure and digital assets, today reported financial results for its fiscal third quarter ended March 31, 2026. Fiscal third quarter results reflected continued progress in iPower’s strategic operating reset following the divestiture of Global Product Marketing Inc. and the Company’s transition toward a leaner, more asset-light operating model. For...

ValOre Metals Announces Non-Brokered Convertible Debenture Financing of up to CAD$2 Million

Written by Customer Service on May 20, 2026. Posted in Public Companies.

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) — ValOre Metals Corp. (“ValOre” or the “Company”) (TSX-V: VO; OTCQB: KVLQF; FRANKFURT: KEQ0) today announced a non-brokered private placement of convertible unsecured debentures (the “Debentures”) for aggregate gross proceeds of up to CDN$2,000,000 (the “Offering”). The Debentures will bear interest at a rate of 6% per annum and will mature on the date that is 18 months from the date of issuance (the “Maturity Date”). The principal amount of the Debentures will be convertible, at the option of the holder at any time after the date six months from the issue date, into units (the “Units”) of the Company at a conversion price of $0.12 per Unit (the “Conversion Price”). Each Unit...

Palvella Therapeutics Presents New SELVA and TOIVA Data at the 2026 International Society for the Study of Vascular Anomalies World Congress Supporting QTORIN™ Rapamycin as a Potential First-in-Disease Therapy for Multiple Serious, Rare Vascular Malformations

Written by Customer Service on May 20, 2026. Posted in Public Companies.

In SELVA Phase 3 study, 100% of participants (13/13) aged 6–11 years were rated as “Much Improved” (+2) or “Very Much Improved” (+3) on the Microcystic Lymphatic Malformation Investigator Global Assessment (mLM-IGA) scale at Week 24, with a mean improvement of +2.46 (p

Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026

Written by Customer Service on May 20, 2026. Posted in Public Companies.

NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 25, 2026 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. The notice of meeting is available on the Cellectis website: https://www.cellectis.com/en/investors/general-meetings/ About Cellectis     Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company utilizes an allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals